CN215384332U - Nasal cavity rapid hemostasis and ventilation device - Google Patents
Nasal cavity rapid hemostasis and ventilation device Download PDFInfo
- Publication number
- CN215384332U CN215384332U CN202121620542.0U CN202121620542U CN215384332U CN 215384332 U CN215384332 U CN 215384332U CN 202121620542 U CN202121620542 U CN 202121620542U CN 215384332 U CN215384332 U CN 215384332U
- Authority
- CN
- China
- Prior art keywords
- air bag
- nasal cavity
- hemostatic
- ventilation device
- nasal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000003928 nasal cavity Anatomy 0.000 title claims abstract description 39
- 238000009423 ventilation Methods 0.000 title claims abstract description 30
- 230000023597 hemostasis Effects 0.000 title claims abstract description 27
- 230000002439 hemostatic effect Effects 0.000 claims abstract description 40
- 238000001125 extrusion Methods 0.000 claims abstract description 39
- 239000000376 reactant Substances 0.000 claims abstract description 19
- 239000000126 substance Substances 0.000 claims abstract description 9
- 230000006698 induction Effects 0.000 claims description 16
- 239000000463 material Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000000835 fiber Substances 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 3
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 3
- 239000004800 polyvinyl chloride Substances 0.000 claims description 3
- 239000008215 water for injection Substances 0.000 claims description 3
- 229920001296 polysiloxane Polymers 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 abstract description 8
- 230000000740 bleeding effect Effects 0.000 abstract description 7
- 208000002193 Pain Diseases 0.000 abstract description 5
- 230000035876 healing Effects 0.000 abstract description 4
- 208000007536 Thrombosis Diseases 0.000 abstract description 3
- 210000000981 epithelium Anatomy 0.000 abstract description 3
- 230000008595 infiltration Effects 0.000 abstract description 3
- 238000001764 infiltration Methods 0.000 abstract description 3
- 230000001788 irregular Effects 0.000 abstract description 3
- 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000036573 scar formation Effects 0.000 abstract description 2
- 239000000499 gel Substances 0.000 description 6
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000001331 nose Anatomy 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 208000032544 Cicatrix Diseases 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 210000003695 paranasal sinus Anatomy 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 230000037387 scars Effects 0.000 description 2
- 206010003497 Asphyxia Diseases 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 235000013559 Schnittsellerie Nutrition 0.000 description 1
- 244000169997 Schnittsellerie Species 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
Images
Landscapes
- Media Introduction/Drainage Providing Device (AREA)
Abstract
The utility model relates to the technical field of medical instruments, in particular to a nasal cavity rapid hemostasis and ventilation device, which comprises an extrusion air bag and a container, wherein hemostasis factors are arranged on the outer surface of the extrusion air bag, and a through air passage is arranged in the extrusion air bag; a reactant is arranged in the container, and the reactant reacts with the hemostatic factor to generate a gel substance; the extrusion air bag can expand along with the shape of the nasal cavity by arranging the extrusion air bag, so that the filling of irregular shapes in the nasal cavity is met; when in use, the reactant and the hemostatic factor are reacted and are stuffed into the nasal cavity to generate a gel substance, which is beneficial to platelet aggregation and rapid formation of blood clots, and simultaneously, an infiltration environment can be formed around a bleeding part to accelerate the formation of epithelial tissues and promote the healing of wound surfaces, thereby reducing and avoiding adhesion and later-stage scar formation, and avoiding the pain of patients when bleeding again and taking out; through the air flue that runs through, can guarantee the ventilation of nasal cavity after the extrusion gasbag is filled the nasal cavity.
Description
Technical Field
The utility model relates to the technical field of medical instruments, in particular to a nasal cavity rapid hemostasis and ventilation device.
Background
The nose comprises an external nose, a nasal cavity and a nasal sinus, the blood circulation is very rich, the nose is closely adjacent to the important peripheral structures such as the cranium, the eye sockets, the oral cavity and the like, severe bleeding is caused after nasal face trauma caused by war injury, traffic injury and various natural disasters, and even the bleeding is accompanied by shock, asphyxiation and aspiration, so the treatment of the epistaxis should firstly pay attention to hemostasis and simultaneously keep the respiratory tract unobstructed; medical nasal PVF hemostatic yarn is adopted in the prior art: the medical material is used for treating epistaxis, filling after nasal cavity operation and a slow release carrier for nasal cavity administration, has high absorbability, quickly expands into a sponge body with high elasticity after imbibing, fills the nasal cavity according to the shape of a filling part, and provides uniform support and compression; although one of the medical sponge PVF hemostatic gauze is widely used in clinic, there are still many disadvantages, including: firstly, after the postoperative PVF is filled, the nasal cavity is completely stuffy, the supporting force is large after the nasal cavity absorbs blood and is completely expanded, and patients who complain about breath, taste, headache and orbital pain are caused the same day after the operation; secondly, when the medical sponge PVF hemostatic gauze is taken out, the pressure is high, the pain degree of a patient is high, and psychological shadow is more likely to be caused to the patient with a small age; thirdly, the medical sponge PVF hemostatic yarn only has the function of compressing the nasal cavity to achieve the purpose of hemostasis, and the surface of the sponge does not contain molecular components such as active substances and the like for promoting the healing of postoperative mucosa; fourthly, the medical sponge PVF hemostatic yarn can not be filled with different filling pressures designed by different patients to achieve the hemostatic effect, and can not be filled individually, and because the pressure is not adjustable, the mucosa is easy to be subjected to ischemic necrosis due to overlarge pressure or overlong time.
Therefore, the research and development of a rapid hemostatic material which is convenient to carry, simple and convenient to operate, and capable of achieving hemostasis and ventilation at the same time is imperative, and the success rate of field first aid is improved; secondly, the hemostasis of packing behind clinical nasal cavity paranasal sinus operation, when giving consideration to the hemostatic effect, alleviate patient's misery, it is also important to promote the comfort level.
SUMMERY OF THE UTILITY MODEL
The technical problem to be solved by the utility model is as follows: provides a nasal cavity rapid hemostasis and ventilation device which can realize rapid hemostasis, reduce scar formation and ventilate.
In order to solve the technical problems, the utility model adopts the technical scheme that:
a nasal cavity rapid hemostasis and ventilation device comprises an extrusion air bag and a container, wherein a hemostasis factor is arranged on the outer surface of the extrusion air bag, and a through air passage is arranged in the extrusion air bag;
the container is provided with a reactant, and the reactant reacts with the hemostatic factor to generate a gel substance.
The utility model has the beneficial effects that: through the arrangement of the extrusion air bag, the extrusion air bag is soft, has better elasticity and conformability, can expand along with the shape of the nasal cavity, meets the requirement of filling irregular shapes in the nasal cavity, and has good hemostatic effect; the hemostatic factor can stimulate the regeneration of blood vessels by activating platelets, reduce the formation of crusts, and when the hemostatic factor is used, a reactant and the hemostatic factor are reacted and are plugged into a nasal cavity to generate a gel substance, so that the platelet aggregation is facilitated, a blood clot is quickly formed, meanwhile, an infiltration environment can be formed around a bleeding part, the formation of epithelial tissues is accelerated, and the healing of a wound surface is promoted, so that the adhesion and the formation of later-stage scars are reduced and avoided, and the pain of a patient during rebleeding and taking out can be avoided; through the air flue that runs through, can guarantee the ventilation of nasal cavity after the extrusion gasbag is filled the nasal cavity.
Drawings
FIG. 1 is a schematic diagram of the combination of the squeeze balloon, the sensing balloon and the valve of the nasal cavity rapid hemostasis ventilation device according to the embodiment of the utility model;
FIG. 2 is a schematic view of the nasal cavity of FIG. 1 in use;
description of reference numerals: 1. extruding the air bag; 2. a breather pipe; 3. sensing an air bag; 4. and (4) a valve.
Detailed Description
In order to explain technical contents, achieved objects, and effects of the present invention in detail, the following description is made with reference to the accompanying drawings in combination with the embodiments.
Referring to fig. 1 and 2, the nasal cavity rapid hemostasis and ventilation device comprises an extrusion air bag 1 and a container, wherein a hemostasis factor is arranged on the outer surface of the extrusion air bag 1, and a through air passage is arranged in the extrusion air bag 1;
the container is provided with a reactant, and the reactant reacts with the hemostatic factor to generate a gel substance.
As can be seen from the above description, through the arrangement of the extrusion air bag 1, the extrusion air bag 1 is soft, has good elasticity and conformability, can expand along with the shape of the nasal cavity, satisfies the filling of irregular shapes in the nasal cavity, and has good hemostatic effect; the hemostatic factor can stimulate the regeneration of blood vessels by activating platelets, reduce the formation of crusts, and when the hemostatic factor is used, a reactant and the hemostatic factor are reacted and are plugged into a nasal cavity to generate a gel substance, so that the platelet aggregation is facilitated, a blood clot is quickly formed, meanwhile, an infiltration environment can be formed around a bleeding part, the formation of epithelial tissues is accelerated, and the healing of a wound surface is promoted, so that the adhesion and the formation of later-stage scars are reduced and avoided, and the pain of a patient during rebleeding and taking out can be avoided; through the air passage that runs through, can guarantee the ventilation of nasal cavity after extrusion gasbag 1 fills the nasal cavity.
Furthermore, a vent pipe 2 is arranged in the air passage, the length ratio of the extrusion air bag 1 to the vent pipe 2 is 4:5, and two ends of the vent pipe 2 extend out of the air passage.
Furthermore, the length of the two ends of the vent pipe 2 extending out of the air passage is 0.8cm respectively.
Further, the silica gel material of breather pipe 2.
Further, the hemostatic factor is disposed on the outer surface of the compression balloon 1 through hemostatic fibers.
As can be seen from the above description, the hemostatic effect can be enhanced by the arrangement of the hemostatic fiber.
Further, the reactant is sterilized distilled water or water for injection.
Further, the container is a syringe.
As can be seen from the above description, by using a syringe, the operation can be facilitated.
Further, the nasal cavity rapid hemostasis and ventilation device further comprises an induction air bag 3, a catheter and a valve 4;
the extrusion air bag 1 is communicated with the induction air bag 3 through a conduit, and the valve 4 is communicated with the induction air bag 3.
From the above description, the pressure condition in the extrusion air bag 1 can be judged by the induction air bag 3, the pressure of the extrusion air bag 1 in the nasal cavity can be sensed, the valve 4 is used for inflating and filling the pressure to pressurize the wound surface and enhance the hemostatic effect, and then the pressure can be automatically adjusted according to the filling time, so that the bleeding can be completely controlled, and the pain of the patient can be relieved to the maximum extent; avoiding the risk of ischemic necrosis due to continuous pressurization.
Furthermore, the material of the extrusion air bag 1, the induction air bag 3 and the conduit is polyvinyl chloride.
As can be seen from the above description, by using the squeeze bag 1 and the sensing bag 3 made of pvc, the uniformity of pressure can be ensured.
Furthermore, a fixed flying wing is arranged on the guide pipe.
From the above description, it can be known that the fixation of the catheter and the induction balloon 3 can be facilitated by the arrangement of the fixed flying wing.
Example one
A nasal cavity rapid hemostasis and ventilation device comprises an extrusion air bag and a container, wherein a hemostasis factor is arranged on the outer surface of the extrusion air bag, and a through air passage is arranged in the extrusion air bag;
the container is provided with a reactant, and the reactant reacts with the hemostatic factor to generate a gel substance.
The air passage is internally provided with an air pipe, the ratio of the length of the extrusion air bag to the length of the air pipe is 4:5, and two ends of the air pipe extend out of the air passage.
The length of the two ends of the vent pipe extending out of the air passage is 0.8cm respectively.
The silica gel material of breather pipe.
The hemostatic factors are arranged on the outer surface of the extrusion air bag through hemostatic fibers (yarns).
The reactant is sterilized distilled water.
The container is a syringe.
The nasal cavity rapid hemostasis and ventilation device also comprises an induction air bag, a catheter and a valve;
the extrusion air bag is communicated with the induction air bag through a conduit, and the valve is communicated with the induction air bag.
The extrusion air bag, the induction air bag and the guide pipe are made of polyvinyl chloride.
The guide pipe is provided with a fixed flying wing.
Example two
A nasal cavity rapid hemostasis and ventilation device comprises an extrusion air bag and a container, wherein a hemostasis factor is arranged on the outer surface of the extrusion air bag, and a through air passage is arranged in the extrusion air bag;
the container is provided with a reactant, and the reactant reacts with the hemostatic factor to generate a gel substance.
A vent pipe is arranged in the air passage, and two ends of the vent pipe extend out of the air passage.
The length of the two ends of the vent pipe extending out of the air passage is 0.8cm respectively.
The silica gel material of breather pipe.
The hemostatic factors are disposed on the outer surface of the extrusion balloon via hemostatic fibers (tourniquets).
The reactant is water for injection.
The container is a syringe.
The nasal cavity rapid hemostasis and ventilation device also comprises an induction air bag, a catheter and a valve; the extrusion air bag is communicated with the induction air bag through a conduit, and the valve is communicated with the induction air bag.
The above description is only an embodiment of the present invention, and not intended to limit the scope of the present invention, and all equivalent changes made by using the contents of the present specification and the drawings, or applied directly or indirectly to the related technical fields, are included in the scope of the present invention.
Claims (10)
1. The nasal cavity rapid hemostasis and ventilation device is characterized by comprising an extrusion air bag and a container, wherein a hemostasis factor is arranged on the outer surface of the extrusion air bag, and a through air passage is arranged in the extrusion air bag;
the container is provided with a reactant, and the reactant reacts with the hemostatic factor to generate a gel substance.
2. The nasal rapid hemostasis and ventilation device of claim 1, wherein a ventilation tube is disposed in the airway, the ratio of the length of the squeeze balloon to the length of the ventilation tube is 4:5, and both ends of the ventilation tube extend out of the airway.
3. The nasal rapid hemostatic ventilation device according to claim 2, wherein the length of the two ends of the ventilation tube extending out of the airway is 0.8 cm.
4. The nasal rapid hemostasis and ventilation device of claim 2, wherein the vent tube is made of silicone.
5. The nasal rapid hemostatic ventilation device according to claim 1, wherein the hemostatic factor is disposed on the outer surface of the squeeze balloon by hemostatic fibers.
6. The nasal rapid hemostatic ventilation device according to claim 1, wherein the reactant is sterilized distilled water or water for injection.
7. The nasal rapid hemostatic ventilation device according to claim 1, wherein the container is a syringe.
8. The nasal rapid hemostatic ventilation device according to claim 1, further comprising an induction balloon, a catheter and a valve;
the extrusion air bag is communicated with the induction air bag through a conduit, and the valve is communicated with the induction air bag.
9. The device as claimed in claim 8, wherein the material of the squeeze balloon, the sensing balloon and the conduit is polyvinyl chloride.
10. The nasal rapid hemostatic ventilation device according to claim 8, wherein the tube is provided with a fixed flying wing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202121620542.0U CN215384332U (en) | 2021-07-16 | 2021-07-16 | Nasal cavity rapid hemostasis and ventilation device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202121620542.0U CN215384332U (en) | 2021-07-16 | 2021-07-16 | Nasal cavity rapid hemostasis and ventilation device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN215384332U true CN215384332U (en) | 2022-01-04 |
Family
ID=79649908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202121620542.0U Active CN215384332U (en) | 2021-07-16 | 2021-07-16 | Nasal cavity rapid hemostasis and ventilation device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN215384332U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113413187A (en) * | 2021-07-16 | 2021-09-21 | 中国人民解放军总医院第四医学中心 | Nasal cavity rapid hemostasis and ventilation device |
-
2021
- 2021-07-16 CN CN202121620542.0U patent/CN215384332U/en active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113413187A (en) * | 2021-07-16 | 2021-09-21 | 中国人民解放军总医院第四医学中心 | Nasal cavity rapid hemostasis and ventilation device |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4137922A (en) | Dilator for cervical canal | |
| US5370656A (en) | Throat pack | |
| US5391179A (en) | Nasal and/or rhinopharyngeal tampon | |
| JP2935743B2 (en) | Irrigation bandage | |
| CN215384332U (en) | Nasal cavity rapid hemostasis and ventilation device | |
| CN209269786U (en) | Air bag for nasal cavity is used in a kind of nursing | |
| CN214074455U (en) | A clog drainage device for going up jaw cyst operation | |
| CN113413187A (en) | Nasal cavity rapid hemostasis and ventilation device | |
| CN204765777U (en) | Nasal cavity haemostat of ventilating | |
| CN218045655U (en) | Novel prevent pressing sore pad | |
| CN208114624U (en) | A kind of tourniquet | |
| CN217310438U (en) | Air bag type compression hemostasis device for bleeding at puncture site of arteriovenous internal fistula | |
| CN215228059U (en) | Nasal cavity double-cavity gel hemostasis air bag | |
| CN204542997U (en) | A kind of pharyngeal fistula negative pressure suction device | |
| CN210330644U (en) | Hemostatic device | |
| CN210354814U (en) | Adjustable nasal cavity air sac hemostat | |
| CN202982116U (en) | Catheter type nasal cavity hemostat | |
| CN209253004U (en) | CEA postoperative wound oppresses U-shaped pillow | |
| CN218922980U (en) | Multilayer dressing | |
| CN215231561U (en) | A nursing device for gynaecology and obstetrics's postoperative resumes | |
| CN219963264U (en) | A kind of compression belt after oral cavity endoscopic surgery | |
| CN221949879U (en) | Arteriovenous internal flaccidity physiotherapy belt | |
| CN111298267A (en) | Wound pain relief system | |
| RU2651057C1 (en) | Method of application of vacuum dressing to head | |
| CN212235594U (en) | Nasal cavity multi-balloon catheter |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant |